NOVARTIS

NOVARTIS

Displaying 10 out of 47 results

  1. FILE PHOTO: The logo of Swiss drugmaker Novartis is pictured at the French company's headquart

    Novartis reaches US$678 million settlement of US fraud lawsuit

    Novartis AG has agreed to pay US$678 million to settle a civil fraud lawsuit in which the U.S. government accused the Swiss drugmaker of ...
  2. FILE PHOTO: Takeda Pharmaceutical Co's logo is seen at its new headquarters in Tokyo

    Japan's Takeda expects US$200 mln operating loss related to Novartis' Xiidra withdrawal

    Takeda Pharmaceutical Co Ltd said on Monday it anticipates an operating loss of about US$200 million related to Novartis AG's decision to ...
  3. FILE PHOTO: A pharmacist displays a box of Hydroxychloroquine at the CHR Centre Hospitalier Regiona

    Novartis halts malaria drug trial against COVID-19 amid participant shortfall

    Swiss drugmaker Novartis is halting its trial of malaria drug hydroxychloroquine (HCQ) against COVID-19 after struggling to find participants, it ...
  4. FILE PHOTO: A logo for Pfizer is displayed on a monitor on the floor at the NYSE in New York

    US states accuse 26 drugmakers of generic drug price fixing in sweeping lawsuit

    Twenty-six drug manufacturers were sued on Wednesday by the attorneys general of most U.S. states and several territories, which accused them of ...
  5. FILE PHOTO: Logo is seen at new factory of Novartis in Stein

    Novartis, Merck and Allergan join those raising US drug prices for 2020

    Novartis AG , Merck & Co Inc and Allergan Plc were among companies that raised U.S. prices on more than 100 prescription medicines on Friday, ...
  6. Logo is seen at new factory of Novartis in Stein

    Novartis in talks with patients upset about lottery-like gene therapy giveaway

    Novartis is in discussion with patient groups over its lottery-style free drug program for its multi-million-dollar gene therapy for spinal ...
  7. FILE PHOTO: Logo is seen at new factory of Novartis in Stein

    Novartis wins Medicaid approval for new sickle cell drug in key US states

    Novartis AG has secured Medicaid coverage for a pricey new sickle cell disease therapy in two U.S. states just weeks after winning U.S. approval, ...
  8. FILE PHOTO: Logo is seen at new factory of Novartis in Stein

    Novartis plans Zolgensma giveaways as some fear 'health lottery'

    Novartis aims to give away 100 doses of its US$2.1 million-per-patient Zolgensma for spinal muscular atrophy (SMA) in 2020 in a free-drug program ...
  9. Logo is seen at new factory of Novartis in Stein

    Novartis to abandon development of asthma drug after trial failures

    Swiss drugmaker Novartis is abandoning development of its drug fevipiprant in asthma after the medicine failed key trials.